tradingkey.logo

Polyrizon Ltd

PLRZ
查看詳細走勢圖
9.430USD
-0.680-6.73%
收盤 12/19, 16:00美東報價延遲15分鐘
55.46M總市值
虧損本益比TTM

Polyrizon Ltd

9.430
-0.680-6.73%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-6.73%

5天

-25.22%

1月

+147.16%

6月

+115.59%

今年開始到現在

-99.71%

1年

-99.60%

查看詳細走勢圖

TradingKey Polyrizon Ltd股票評分

單位: USD 更新時間: 2025-10-27

操作建議

當前估值合理,機構持股佔比非常高,目前股價在壓力位和支撐位之間,可以做區間波段操作。

Polyrizon Ltd評分

相關信息

行業排名
299 / 501
全市場排名
564 / 4682
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Polyrizon Ltd亮點

亮點風險
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
利潤高增長
公司淨利潤處於行業前列,最新年度總收入0.00美元
估值合理
公司最新PE估值-2.14,處於3年歷史合理位
機構加倉
最新機構持股370.57K股,環比增加49.99%

Polyrizon Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Polyrizon Ltd簡介

Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
公司代碼PLRZ
公司Polyrizon Ltd
CEOIzraeli (Tomer)
網址https://polyrizon-biotech.com/

常見問題

Polyrizon Ltd(PLRZ)的當前股價是多少?

Polyrizon Ltd(PLRZ)的當前股價是 9.430。

Polyrizon Ltd 的股票代碼是什麼?

Polyrizon Ltd的股票代碼是PLRZ。

Polyrizon Ltd股票的52週最高點是多少?

Polyrizon Ltd股票的52週最高點是4590.000。

Polyrizon Ltd股票的52週最低點是多少?

Polyrizon Ltd股票的52週最低點是2.880。

Polyrizon Ltd的市值是多少?

Polyrizon Ltd的市值是55.46M。

Polyrizon Ltd的淨利潤是多少?

Polyrizon Ltd的淨利潤為-1.60M。

現在Polyrizon Ltd(PLRZ)的股票是買入、持有還是賣出?

根據分析師評級,Polyrizon Ltd(PLRZ)的總體評級為--,目標價格為--。

Polyrizon Ltd(PLRZ)股票的每股收益(EPS TTM)是多少

Polyrizon Ltd(PLRZ)股票的每股收益(EPS TTM)是-97.075。
KeyAI